326
Views
0
CrossRef citations to date
0
Altmetric
Poison Centre Research

Toxicity of acute exploratory amphetamine-salt medication in amphetamine-naïve pediatrics: a retrospective cohort study

ORCID Icon, &
Pages 907-912 | Received 30 Sep 2019, Accepted 03 Dec 2019, Published online: 08 Jan 2020

References

  • Spiller HA, Hays HL, Aleguas A. Overdose of drugs for attention-deficit hyperactivity disorder: clinical presentation, mechanisms of toxicity, and management. CNS Drugs. 2013;27(7):531–543.
  • Subcommittee on Attention-Deficit/Hyperactivity Disorder, Steering Committee on Quality Improvement and Management. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2011;128(5):1007–1022.
  • LoVecchio F, Ozimek J, Sawyers B, et al. Outcomes after accidental pediatric ingestions of (dextro)amphetamine and methylphenidate. Am J Emerg Med. 2009;27(8):933–934.
  • Derlet RW, Rice P, Horowitz BZ, et al. Amphetamine toxicity: experience with 127 cases. J Emerg Med. 1989;7(2):157–161.
  • Zalis EG, Parmley LF. Fafal amphetamine poisoning. Arch Intern Med. 1963;112(6):822–826.
  • King SA, Casavant MJ, Spiller HA, et al. Pediatric ADHD medication exposures reported to US poison control centers. Pediatrics. 2018;141(6):e20173872–13.
  • Wood KE, McCarthy PJ, Krasowski MD. A case series involving young children presenting with accidental ingestion of amphetamine based stimulants. Toxicol Rep. 2018;5:1129–1133.
  • Scharman EJ, Erdman AR, Cobaugh DJ, et al. Methylphenidate poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila). 2007;45(7):737–752.
  • Huffman RM, McCaughey J, Hays H, et al. Lisdexamfetamine (Vyvanse(r)) exposure in children 5 years of age and under: stay or go? is a trip the emergency department necessary? (abstract). Clin Toxicol (Phila). 2013;51(7):599.
  • Biederman J, Lopez FA, Boellner SW, et al. A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit/hyperactivity disorder. Pediatrics. 2002;110(2):258–266.
  • Ahmann PA, Theye FW, Berg R, et al. Placebo-controlled evaluation of amphetamine mixture-dextroamphetamine salts and amphetamine salts (Adderall): efficacy rate and side effects. Pediatrics. 2001;107(1):E10–e10.
  • Novak MJ, DesLauriers C, Wahl M. Pediatric ingestions of amfetamine/dextroamfetamine salts (abstract). Clin Toxicol (Phila). 2017;55(7):720–721.
  • Catalá-López F, Hutton B, Núñez-Beltrán A, et al. The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: a systematic review with network meta-analyses of randomised trials. PLoS One. 2017;12(7):e0180355.
  • Ermer JC, Adeyi BA, Pucci ML. Pharmacokinetic variability of long-acting stimulants in the treatment of children and adults with attention-deficit hyperactivity disorder. CNS Drugs. 2010;24(12):1009–1025.
  • Spiller HA, Bosse GM, Beuhler M, et al. Unintentional ingestion of bupropion in children. J Emerg Med. 2010;38(3):332–336.
  • Hays H, Beuhler MC, Spiller HA. Adverse outcomes after single acute methotrexate exposures in pediatric patients are rare. Clin Toxicol (Phila). 2018;56(9):870–871.
  • Hays H, Beuhler MC, Spiller HA, et al. Evaluation of toxicity after acute accidental methotrexate ingestions in children under 6 years old: a 16-year multi-center review. Clin Toxicol (Phila). 2018;56(2):120–125.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.